Using iron nanoparticles to enhance stem cell function for tissue regeneration
Official title: Repurposing Ferumoxytol Nanoparticles to Promote Orofacial Stem Cell Function for Autotherapies
Funded at University of Pennsylvania · NIH-10988797 · Data updated 2026-11-12
This study is looking at how a special iron-based treatment called ferumoxytol can help improve the healing abilities of certain stem cells in your face and jaw, which could lead to better ways to fix bone problems in those areas.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 12, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $243,750 |
| NIH project number | 1R21DE033128-01A1 |
| Project ID | NIH-10988797 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 years old who have conditions related to craniofacial bone defects or chronic kidney failure.
✕Less likely to help
Patients with conditions unrelated to craniofacial bone defects or those under 21 years old may not benefit from this research.
What this research studies
This research investigates the use of ferumoxytol, an FDA-approved iron oxide nanoparticle, to enhance the function of orofacial mesenchymal stem cells (MSCs) for regenerative medicine. The study aims to understand how ferumoxytol can activate these stem cells, promoting their ability to differentiate and regenerate hard tissues, particularly in the context of craniofacial bone defects. Through advanced techniques like RNA sequencing and in vitro characterization, the researchers will explore the mechanisms by which ferumoxytol influences stem cell behavior, potentially leading to new therapies for tissue regeneration.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for craniofacial bone defects, improving healing and regeneration in affected patients.
How similar studies have gone: While the use of ferumoxytol in this specific context is novel, similar approaches using nanoparticles for stem cell enhancement have shown promise in other studies.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Chen, Chi-Der — University of Pennsylvania
- Study coordinator: Chen, Chi-Der
Related research
Other NIH-funded projects on the same topics.
-
Comparing universal and guideline-directed genetic testing for young adults with cancer
This study is looking at whether a broader genetic test can help young adults with cancer find inherited risks that regular tests might miss, so they can get better treatment and care tailored just for them.
-
Better, searchable data for human pain biology
A data integration center will standardize, combine, and share molecular and cellular data from human pain research to help scientists understand how pain works and to accelerate discoveries.
-
Understanding how sweat glands form and work to help burn and skin injury patients
A study at the University of Pennsylvania looks at how sweat glands develop and function, with the goal of informing treatments for people who suffer traumatic skin injuries.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Understanding how a special airway cell helps protect and repair breathing passages
A researcher is studying a newly found airway cell called the hillock to see how it protects the airways and helps repair them after injury, with the aim of helping people with asthma, COPD, or bronchiectasis.
-
Defining TMJ cartilage progenitors and their regulatory niche for TMJ regeneration
Researchers are studying the cells that could help repair the jaw’s cartilage in TMJ osteoarthritis to lay the groundwork for regenerative therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.